DUPHALAC

This brand name is authorized in Austria, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Lithuania, Malta, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug DUPHALAC contains one active pharmaceutical ingredient (API):

1 Lactulose UNII 9U7D5QH5AE - LACTULOSE

Lactulose is a synthetic disaccharide which is metabolised by gastro-intestinal bacterial flora to low molecular weight acids (chiefly lactic and acetic acids). There is no endogenous metabolising enzyme in the human gut. Its mode of action in constipation is as an osmotic agent producing soft stools. Read about Lactulose

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DUPHALAC Oral solution	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A06AD11	Lactulose	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AD Osmotically acting laxatives
Discover more medicines within A06AD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 500214050031818, 500216070034803, 500220040045107
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 361560812
Country: EE	Ravimiamet	Identifier(s): 1051131, 1063213, 1063224, 1117493, 1354676, 1354755, 1354777, 1354788, 1354799, 1356151
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 46197, 60189
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 082669, 088287, 450346, 450353
Country: FR	Base de données publique des médicaments	Identifier(s): 60155329, 62729121
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 15029, 15031, 15035
Country: HK	Department of Health Drug Office	Identifier(s): 32072
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-686529569, HR-H-833932438
Country: IE	Health Products Regulatory Authority	Identifier(s): 22551, 22594
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1007049, 1007050, 1007051, 1032888, 1033341, 1050949, 1050950, 1050951, 1050952, 1067322, 1070746, 1075415
Country: MT	Medicines Authority	Identifier(s): MA1507/00501, PI1438/05101A
Country: NG	Registered Drug Product Database	Identifier(s): 04-1331
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 120162, 892
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 793
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100196595, 100220371, 100222766, 100304820, 100414632
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68670001, W68670002, W68670003, W68670004, W68670005, W68670006
Country: SG	Health Sciences Authority	Identifier(s): 02818P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 9253121, 9253122
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699820570217, 8699820570224
Country: ZA	Health Products Regulatory Authority	Identifier(s): 28/11.5/0427, K/11.5/180